Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome

Lupus

Volumn 21, Issue 14, 2012, Pages 1506-1514

  Fujieda, Y ^a   Atsumi, T ^a   Amengual, O ^a   Odani, T ^a   Otomo, K ^a   Kato, M ^a   Oku, K ^a   Kon, Y ^a   Horita, T ^a   Yasuda, S ^a   Koike, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticardiolipin antibody; antiphospholipid antibodies; antiprothrombin antibody; arterial thrombosis; lupus anticoagulant; obstetric complications; phosphatidylserine dependent; venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE DEPENDENT ANTIPROTHROMBIN ANTIBODY; PROTHROMBIN ANTIBODY; STEROID; UNCLASSIFIED DRUG; WARFARIN;

ABORTION; ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; CENTRAL RETINA VEIN OCCLUSION; CHILD; DEEP VEIN THROMBOSIS; FEMALE; FETUS WASTAGE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPANESE; KIDNEY INFARCTION; LEG ISCHEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MESENTERIC ARTERY OCCLUSION; PHYSICAL EXAMINATION; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLEEN INFARCTION; SUPERFICIAL THROMBOPHLEBITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; THROMBOSIS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84869402244     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312458469     Document Type: Article

References (37)

1. Atsumi T, Amengual O, Koike T Systemic lupus erythematosus. 5 th edn. San Diego: Academic press, 2011; 945-965. Lahita RG, ed. San Diego: Academic press ; 2011: 945-965.
2. Harris EN, Gharavi AE, Boey ML, et al. Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 ; ii: 1211-1214
3. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995 ; 74: 1185-1190
4. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990 ; 335: 952-953
5. Matsuura E, Igarashi Y, Fujimoto M, et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990 ; 336: 177-178
6. McNeil HP, Simpson RJ, Chesterman CN, et al. Anti-phospholipid antibodies are directed against a complex antigen that induces a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 1990 ; 87: 4120-4124
7. Bevers EM, Galli M, Barbui T, et al. Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost. 1991 ; 66: 629-632
8. Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed). 1983 ; 287: 1088-1089
9. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 ; 42: 1309-1311
10. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 ; 46: 1019-1027
11. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
13. Harris EN, Gharavi AE, Patel BM, et al. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 ; 68: 215-222
14. Amengual O, Atsumi T, Khamashta MA, et al. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol. 1996 ; 35: 1239-1243
15. Atsumi T, Ieko M, Bertolaccini ML, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 2000 ; 43: 1982-1993
16. Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis. 2011 ; 70: 1083-1086
17. Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis. 2009 ; 68: 397-399
18. Erkan D, Yazici Y, Peterson MG, et al. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford). 2002 ; 41: 924-929
19. Danowski A, de Azevedo MN, de Souza Papi JA, et al. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 1195-1199
20. Mtabaji JP, Moriguchi Y, Nara Y, et al. Ethnic differences in salt sensitivity: genetic or environmental factors?. Clin Exp Pharmacol Physiol Suppl. 1992 ; 20: 65-67
21. Sakuma M, Nakamura M, Yamada N, et al. Venous thromboembolism: deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone. Circ J. 2009 ; 73: 305-309
22. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003 ; 25: 1-5
23. Roubey RA. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice. Lupus. 2010 ; 19: 440-445
24. Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009 ; 8: 998-1005
25. Naess IA, Christiansen SC, Cannegieter SC, et al. A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). J Thromb Haemost. 2006 ; 4: 44-49
26. de Groot PG, Lutters B, Derksen RH, et al. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost. 2005 ; 3: 1993-1997
27. Otomo K, Atsumi T, Amengual O, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012 ; 64: 504-512
28. Exner T, Hohnen-Behrens C, Newman P, et al. Effect of instruments on lupus anticoagulant testing. Thromb Haemost. 2000 ; 83: 345-348
29. Galli M, Luciani D, Bertolini G, et al. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003 ; 102: 2717-2723
30. Reber G, Tincani A, Sanmarco M, et al. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost. 2004 ; 2: 1860-1862
31. Faden D, Tincani A, Tanzi P, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1997 ; 73: 37-42
32. Lee RM, Branch DW, Silver RM. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol. 2001 ; 185: 748-753
33. Ambrozic A, Avicin T, Ichikawa K, et al. Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol. 2002 ; 14: 823-830
34. Arvieux J, Darnige L, Caron C, et al. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost. 1995 ; 74: 1120-1125
35. Galli M, Beretta G, Daldossi M, et al. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost. 1997 ; 77: 486-491
36. Galli M, Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood. 1999 ; 93: 2149-2157
37. Atsumi T, Koike T. Antiprothrombin antibody: why do we need more assays?. Lupus. 2010 ; 19: 436-439